280 related articles for article (PubMed ID: 30974173)
21. How sequential studies inform drug development: evaluating the effect of food intake on optimal bioavailability of ziprasidone.
Lincoln J; Stewart ME; Preskorn SH
J Psychiatr Pract; 2010 Mar; 16(2):103-14. PubMed ID: 20511734
[TBL] [Abstract][Full Text] [Related]
22. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine.
Dresser GK; Bailey DG; Leake BF; Schwarz UI; Dawson PA; Freeman DJ; Kim RB
Clin Pharmacol Ther; 2002 Jan; 71(1):11-20. PubMed ID: 11823753
[TBL] [Abstract][Full Text] [Related]
23. Influence of dietary substances on intestinal drug metabolism and transport.
Won CS; Oberlies NH; Paine MF
Curr Drug Metab; 2010 Nov; 11(9):778-92. PubMed ID: 21189136
[TBL] [Abstract][Full Text] [Related]
24. Effect of Coadministered Water on the In Vivo Performance of Oral Formulations Containing N-Acetylcysteine: An In Vitro Approach Using the Dynamic Open Flow-Through Test Apparatus.
Sager M; Schneider F; Jedamzik P; Wiedmann M; Schremmer E; Koziolek M; Weitschies W
Mol Pharm; 2017 Dec; 14(12):4272-4280. PubMed ID: 29064257
[TBL] [Abstract][Full Text] [Related]
25. Effects of Food Intake on the Relative Bioavailability of Amifampridine Phosphate Salt in Healthy Adults.
Haroldsen PE; Musson DG; Hanson B; Quartel A; O'Neill CA
Clin Ther; 2015 Jul; 37(7):1555-63. PubMed ID: 26101174
[TBL] [Abstract][Full Text] [Related]
26. Food and drugs.
Daković-Svajcer K
Med Pregl; 2002; 55(1-2):5-12. PubMed ID: 12037939
[TBL] [Abstract][Full Text] [Related]
27. Drug dissolution: significance of physicochemical properties and physiological conditions.
Jambhekar SS; Breen PJ
Drug Discov Today; 2013 Dec; 18(23-24):1173-84. PubMed ID: 24042023
[TBL] [Abstract][Full Text] [Related]
28. Interactions between grapefruit juice and cardiovascular drugs.
Bailey DG; Dresser GK
Am J Cardiovasc Drugs; 2004; 4(5):281-97. PubMed ID: 15449971
[TBL] [Abstract][Full Text] [Related]
29. Drug-drug and food-drug pharmacokinetic interactions with new insulinotropic agents repaglinide and nateglinide.
Scheen AJ
Clin Pharmacokinet; 2007; 46(2):93-108. PubMed ID: 17253883
[TBL] [Abstract][Full Text] [Related]
30. Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling.
Shono Y; Jantratid E; Janssen N; Kesisoglou F; Mao Y; Vertzoni M; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2009 Sep; 73(1):107-14. PubMed ID: 19465123
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of food effect on the oral absorption of clarithromycin from immediate release tablet using physiological modelling.
Radwan A; Jayyousi R; Shraim N; Zaid AN
Biopharm Drug Dispos; 2019 Apr; 40(3-4):121-134. PubMed ID: 30891805
[TBL] [Abstract][Full Text] [Related]
32. Simulating Different Dosing Scenarios for a Child-Appropriate Valproate ER Formulation in a New Pediatric Two-Stage Dissolution Model.
Karkossa F; Krueger A; Urbaniak J; Klein S
AAPS PharmSciTech; 2017 Feb; 18(2):309-316. PubMed ID: 27909943
[TBL] [Abstract][Full Text] [Related]
33. Effect of fruit juices on the oral bioavailability of fexofenadine in rats.
Kamath AV; Yao M; Zhang Y; Chong S
J Pharm Sci; 2005 Feb; 94(2):233-9. PubMed ID: 15570603
[TBL] [Abstract][Full Text] [Related]
34. Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications.
Fleisher D; Li C; Zhou Y; Pao LH; Karim A
Clin Pharmacokinet; 1999 Mar; 36(3):233-54. PubMed ID: 10223170
[TBL] [Abstract][Full Text] [Related]
35. [Recent advances in drug dissolution/permeation synchronous evaluation technologies based on physiological characteristics of gastrointestinal tract].
Li ZQ; He X; Liu CX
Yao Xue Xue Bao; 2016 Oct; 51(10):1540-50. PubMed ID: 29932598
[TBL] [Abstract][Full Text] [Related]
36. Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modelling.
Jones HM; Parrott N; Ohlenbusch G; Lavé T
Clin Pharmacokinet; 2006; 45(12):1213-26. PubMed ID: 17112297
[TBL] [Abstract][Full Text] [Related]
37. A short review of drug-food interactions of medicines treating overactive bladder syndrome.
Paśko P; Rodacki T; Domagała-Rodacka R; Owczarek D
Int J Clin Pharm; 2016 Dec; 38(6):1350-1356. PubMed ID: 27738922
[TBL] [Abstract][Full Text] [Related]
38. Food-drug interaction: grapefruit juice augments drug bioavailability--mechanism, extent and relevance.
Dahan A; Altman H
Eur J Clin Nutr; 2004 Jan; 58(1):1-9. PubMed ID: 14679360
[TBL] [Abstract][Full Text] [Related]
39. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
[TBL] [Abstract][Full Text] [Related]
40. The effect of food on the absorption and pharmacokinetics of rivaroxaban.
Stampfuss J; Kubitza D; Becka M; Mueck W
Int J Clin Pharmacol Ther; 2013 Jul; 51(7):549-61. PubMed ID: 23458226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
